Express Pharma

BDR Pharma launches biapenem to treat intra-abdominal, lower respiratory or complicated urinary tract infections

0 793

BIAPENEM is launched under the brand name BIAPEN, in addition to their existing vast range of antibiotics

BDR Pharma has announced the launch of BIAPENEM to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections.

BIAPENEM is launched under the brand name BIAPEN, in addition to their existing vast range of antibiotics

BDR Pharma was the first to identify and develop this product and conducted clinical studies in conjunction with some of the leading players in the critical care segment who co-sponsored these studies. It was also the first one to get the DCGI (Drug Controller General of India) approval for this drug.

Marching towards the new milestone, Raheel Shah, Director-Bu